PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))

Term ID

CHEBI:88914

Synonyms

(2-{[(2R)-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-2-[(11Z)-octadec-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Eicsoate
1-Eicsoatetraenoyl-2-vaccenoyl-sn-glycero-3-phosphocholine
1-Eicsoic acid
GPCho(20:4/18:1)
GPCho(20:4n3/18:1n7)
GPCho(20:4w3/18:1w7)
GPCho(38:5)
Lecithin
PC aa C38:5
PC(20:4/18:1)
PC(20:4n3/18:1n7)
PC(20:4w3/18:1w7)
PC(38:5)
Phosphatidylcholine(20:4/18:1)
Phosphatidylcholine(20:4n3/18:1n7)
Phosphatidylcholine(20:4w3/18:1w7)
Phosphatidylcholine(38:5)

(all 18)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))

Phenotype where environments contain PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))

Phenotype modified by environments containing PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))

Phenotype affecting PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))

Human Disease Model